Drug Distributors and J.&J. Reach $26 Billion Deal to End Opioids Lawsuitsnews2021-07-21T23:24:01+00:00July 21st, 2021|The New York Times|
J.&J. Vaccine May Be Less Effective Against Delta, Study Suggestsnews2021-07-20T21:20:49+00:00July 20th, 2021|The New York Times|
States and Cities Near Tentative $26 Billion Deal in Opioids Casesnews2021-07-20T21:16:11+00:00July 20th, 2021|The New York Times|
Drug Companies to Pay N.Y. More Than $1 Billion to Settle Opioid Lawsuitnews2021-07-20T20:40:18+00:00July 20th, 2021|The New York Times|
Johnson & Johnson Recalls Sunscreen Because of Benzene Tracesnews2021-07-15T01:19:37+00:00July 15th, 2021|The New York Times|
F.D.A. Attaches Warning of Rare Nerve Syndrome to Johnson & Johnson Covid Vaccinenews2021-07-13T02:28:00+00:00July 13th, 2021|The New York Times|
